Man-specific lectins from plants, fungi, algae and cyanobacteria, as potential blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) coronaviruses : biomedical perspectives Ghent University
Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (immunodiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots Ghent University
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity University of Antwerp KU Leuven Institute of Tropical Medicine Ghent University
Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays University of Antwerp
Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission Hasselt University University of Antwerp KU Leuven
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff : study protocol description and presentation of preliminary findings on symptoms Ghent University University of Antwerp Institute of Tropical Medicine
Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice Institute of Tropical Medicine
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes respiratory disease, but it can also affect other organs including the central nervous system. Several animal models have been developed to address different key questions related to Coronavirus Disease 2019 (COVID-19). Wild-type mice are minimally susceptible to certain SARS-CoV-2 lineages (beta and gamma variants), whereas hACE2-transgenic mice succumb to SARS-CoV-2 and ...
Variant analysis of SARS-CoV-2 genomes from Belgian military personnel engaged in overseas missions and operations Institute of Tropical Medicine University of Antwerp KU Leuven
More than a year after the first identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the causative agent of the 2019 coronavirus disease (COVID-19) in China, the emergence and spread of genomic variants of this virus through travel raise concerns regarding the introduction of lineages in previously unaffected regions, requiring adequate containment strategies. Concomitantly, such introductions fuel worries about ...
Specificity of SARS-CoV-2 antibody detection assays against S and N proteins among pre-COVID-19 sera from patients with protozoan and helminth parasitic infections Institute of Tropical Medicine
We aimed to assess the specificity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody detection assays among people with tissue-borne parasitic infections. We tested three SARS-CoV-2 antibody-detection assays (cPass SARS-CoV-2 neutralization antibody detection kit [cPass], Abbott SARS-CoV-2 IgG assay [Abbott Architect], and Standard Q COVID-19 IgM/IgG combo rapid diagnostic test [SD RDT IgM/SD RDT IgG]) among 559 ...